Login

HealthBeacon is among four nominees in the Intelligent Automation - Best Use of RPA & Cognitive category, aiming to win the top award. 00:10:00

Share On Facebook Share On Twitter

The chief executive of HealthBeacon, Jim Joyce

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
The Future is User Owned|Jesse Walden,Founder and General Partner,Variant
00:10:00
Terralek Resources: Driving Growth in the Lithium Race Across Canada and the U.S.
00:10:00
Delisting Not on the Agenda" | Francis Van Eeckhout (Deceuninck) | CEO Talk | Francis Van Eeckhout - CEO of Deceuninck
00:10:00
Empowering Customers and Enhancing Support Services | Louise Beardmore, CEO, United Utilities Group PLC.
00:10:00
Jeff Holmgren Discusses Trees Corp.'s NEO Debut and Growth Plans | Jeff Holmgren , CFO, Trees Corporation.
00:10:00
opportunity for moving what they do further into the mainstream of the capital markets|Ela Madej,General Partner, Fifty Years
00:10:00
Tom Barrack on Real Estate Repricing, Digital Infrastructure, and the Presidential Election |Tom Barrack, Founder, Colony Capital.
00:10:00
Patrick Decostre, President and CEO of Boralex, explores current and future renewable energy strategies in a discussion.
00:10:00
Jim Coulter on TPG's Climate Strategy and the Economic Revolution Ahead | Jim Coulter, CO-CEO, TPG Capital.
00:10:00
Annie Dear and Nick Centenio on Navigating the RFP Process for Non-Profits
00:10:00
The Philanthropic Spirit of Syverson Strege | Johnne Syverson, Strategic Advisor of Syverson Strege
00:00:00
Satyajit T. Reddy, M.D. Cardiologist, Mayo Clinic

© 2026 Nehu